Clinical trials
Terminated Heart Defects, Congenital trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 8 |
| Children's Healthcare of Atlanta | 7 |
| Boston Children's Hospital | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| University of California, Los Angeles | 2 |
| University of Michigan | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Artivion Inc. | 1 |
| Aymen N Naguib | 1 |
| Cardurion Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Defects, Congenital | 43 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 3 |
| Heart Failure | 3 |
| Hypoplastic Left Heart Syndrome | 3 |
| Cyanosis | 2 |
| Heart Septal Defects, Ventricular | 2 |
| Tachycardia, Ventricular | 2 |
| Acute Coronary Syndrome | 1 |
| Acute Kidney Injury | 1 |
| Anemia | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.